Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HPV
Pharma
FDA approves Precigen's Papzimeos for HPV-related disorder
The FDA has approved a treatment for recurrent respiratory papillomatosis for the first time, signing off on Precigen’s immunotherapy Papzimeos.
Kevin Dunleavy
Aug 15, 2025 8:55am
China's 9-valent HPV vaccine priced at 60% discount to Merck jab
Jul 10, 2025 11:10am
Merck triumphs in Gardasil safety litigation covering 200+ suits
Mar 12, 2025 11:03am
Merck in HPV awareness day push in China as Gardasil underwhelms
Mar 4, 2025 11:40am
Merck, plaintiff agree to hit the brakes on CA Gardasil trial
Feb 20, 2025 11:50am
Merck halts Gardasil shipments to China, pulls $11B sales target
Feb 4, 2025 12:10pm
